NDC 27293-024-14 - Budpak Triple Antibiotic Maximum Strength

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
27293-024
Requested NDC
27293-024-14
Package NDCs from labels
27293-024-14, 27293-024-01
Manufacturer
Budpak Inc. | Anicare Pharmaceuticals Pvt. Ltd
Effective date
2013-06-11
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
BACITRACIN ZINC - Budpak Inc. | Anicare Pharmaceuticals Pvt. LtdBudpak Inc. | Anicare Pharmaceuticals Pvt. Ltd2013-06-11HUMAN OTC DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
27293-024-012020-01-31C16284748780-19d75b9d0-c1f6-f424-e053-dadaa90a57ce55e236e6-48b8-4391-b60f-7dcc5b5ecff7

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
27293-024-01Budpak Triple Antibiotic Maximum Strength1 in 1 BOXOINTMENT12
27293-024-14Budpak Triple Antibiotic Maximum Strength14 g in 1 TUBEOINTMENT142

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
27293-024BUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2Legacy NDC, 2 package rows20130611_55e236e6-48b8-4391-b60f-7dcc5b5ecff7.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BACITRACIN ZINCACTIVE INGREDIENT89Y4M234ESBUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2
NEOMYCIN SULFATEACTIVE INGREDIENT057Y626693BUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2
POLYMYXIN B SULFATEACTIVE INGREDIENT19371312D4BUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2
BACITRACINACTIVE MOIETY58H6RWO52IBUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2
NEOMYCINACTIVE MOIETYI16QD7X297BUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2
POLYMYXIN BACTIVE MOIETYJ2VZ07J96KBUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2
.ALPHA.-TOCOPHEROL ACETATEINACTIVE INGREDIENT9E8X80D2L0BUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2
COCOA BUTTERINACTIVE INGREDIENT512OYT1CRRBUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2
COTTONSEED OILINACTIVE INGREDIENTH3E878020NBUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2
OLIVE OILINACTIVE INGREDIENT6UYK2W1W1EBUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2
PETROLATUMINACTIVE INGREDIENT4T6H12BN9UBUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2
SODIUM PYRUVATEINACTIVE INGREDIENTPOD38AIF08BUDPAK TRIPLE ANTIBIOTIC MAXIMUM STRENGTH (BACITRACIN ZINC, NEOMYCIN SULFATE AND POLYMYXIN B SULFATE) OINTMENT [BUDPAK INC. ]2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 34 of 54 · 1,069 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Triple AntibioticBACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATETrifecta Pharmaceuticals USA LLC087694c2-4b1b-e293-e063-6294a90a961f2024-12-31WarningsExact identifier
rxcui: 204602
unii: 89Y4M234ES
unii: 057Y626693
unii: 19371312D4
Triple AntibioticBACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATETRIFECTA PHARMACEUTICALS USA LLC0c017b10-29b6-e30f-e063-6294a90a8a3c2024-12-31WarningsExact identifier
rxcui: 204602
unii: 89Y4M234ES
unii: 057Y626693
unii: 19371312D4
Triple Antibiotic and Pain ReliefBACITRACIN,NEOMYCIN,POLYMYXINB,PRAMOXINETrifecta Pharmaceutical USA LLC0bf08cf6-be3f-f9aa-e063-6294a90a43932024-12-31WarningsExact identifier
unii: 89Y4M234ES
unii: 057Y626693
unii: 19371312D4
Vitamin A and DPETROLATUMTrifecta Pharmaceuticals USA LLCf1ea9640-4a6d-1c76-e053-2a95a90ad3b12024-12-31WarningsExact identifier
unii: 4T6H12BN9U
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONENEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONEAdvanced Rx Pharmacy of Tennessee, LLCf1a05d5f-74f2-17a1-e053-2995a90ab0e72024-12-31Warnings, Adverse reactionsExact identifier
unii: 057Y626693
unii: 19371312D4
A and D Diaper Rash and Skin ProtectantLANOLIN AND PETROLATUMNatureplex LLCfcaf27c9-3634-4fb7-a311-2e093f0552782024-12-31WarningsExact identifier
unii: 4T6H12BN9U
Neomycin and Polymyxin B Sulfates and DexamethasoneNEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONENuCare Pharmaceuticals,Inc.a7e55c43-4345-4710-e053-2995a90aeee72024-12-30Warnings, Adverse reactionsExact identifier
unii: 057Y626693
unii: 19371312D4
Single Antibiotic with BacitracinBACITRACIN ZINCRandob Labs Ltd.2a807f1b-986f-a9ea-e063-6394a90aed252024-12-30WarningsExact identifier
unii: 89Y4M234ES
Bacitracin Zinc and Polymyxin B SulfateBACITRACIN ZINC AND POLYMYXIN B SULFATENuCare Pharmaceuticals,Inc.a73654f4-949d-3da4-e053-2995a90a1fc32024-12-30Warnings, Adverse reactionsExact identifier
unii: 89Y4M234ES
unii: 19371312D4
ELIZABETH ARDEN EIGHT HR PROTECTANT CLEARLIP PROTECTANTREVLON CONSUMER PRODUCTS CORPf3a6fe29-7af7-bfb1-e053-2a95a90a01012024-12-30WarningsExact identifier
unii: 4T6H12BN9U
EIGHT HOUR LIP PROTECTANT SPF 15PETROLATUM, OXYBENZONE, OCTINOXATE, AVOBENZONEREVLON2a0ac6aa-0315-d79e-e063-6294a90a9c532024-12-24WarningsExact identifier
unii: 4T6H12BN9U
CUREFINIPETROLATUM, COD LIVER OILMiramar Cosmetics, Inc DBA Miramar Labfc9211db-71aa-44d8-a00b-65f1482d39812024-12-23WarningsExact identifier
unii: 4T6H12BN9U
CUREFINIPETROLATUMMiramar Cosmetics, Inc DBA Miramar Lab6a2610ca-ca80-451f-8fed-b982443a10b92024-12-23WarningsExact identifier
unii: 4T6H12BN9U
TripleantibioticapainscaritchFAMILY WELLNESS BACITRACIN,NEOMYCIN,POLYMYXINB,PRAMOXINEHCLTrifecta Pharmaceutical USA LLC935106c6-8a9e-07fa-e053-2a95a90a24842024-12-20WarningsExact identifier
unii: 057Y626693
unii: 19371312D4
Triple AntibioticBACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE.TRIFECTA PHARMACEUTICALS USA LLC00c52a31-9bfa-a8bf-e063-6294a90ac4d72024-12-20WarningsExact identifier
rxcui: 204602
unii: 89Y4M234ES
unii: 057Y626693
unii: 19371312D4
Triple AntibioticBACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATETrifecta Pharmaceuticals Usa Llcd04b397c-1608-4fd9-be28-ef7285d6a9962024-12-20WarningsExact identifier
rxcui: 204602
unii: 89Y4M234ES
unii: 057Y626693
unii: 19371312D4
Vitamin A and DLANOLIN, PETROLATUMTrifecta Pharmaceuticals USA LLC453dffec-de9d-0eac-e054-00144ff8d46c2024-12-20WarningsExact identifier
unii: 4T6H12BN9U
Vitamin A and DLANOLIN, PETROLATUMTrifecta Pharmaceuticals USA LLC455a16fd-9ce5-6bef-e054-00144ff88e882024-12-20WarningsExact identifier
unii: 4T6H12BN9U
TripleantibioticointmentandpainreliefFAMILY WELLNESS BACITRACIN,NEOMYCIN,POLYMYXINB,PRAMOXINETrifecta Pharmaceutical USA LLC91575333-5268-5d8f-e053-2a95a90a7a892024-12-20WarningsExact identifier
unii: 057Y626693
unii: 19371312D4
White PetrolatumPETROLATUMTrifecta Pharmaceuticals USA LLCf1eb0ec2-98e7-13a2-e053-2a95a90a29382024-12-20WarningsExact identifier
unii: 4T6H12BN9U

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.